Riding the wave of NFT popularity, game development company iCandy Interactive (ASX: ICI) has confirmed their first NFT-based game, League…
Starbucks never really took off in Australia. We just couldn’t get behind the sickly sweet, whipped cream covered combos that…
With concentrated initiatives to convert years of R&D into profitability, water tech company De.mem (ASX: DEM) finally has that in…
As is becoming the case across the consumer products industry, millenials are wielding unprecedented power through irrational spending and influencer…
Noxopharm (ASX: NOX) will hopefully see an increase in value of their flagship drug following this morning’s announcement. The Company has…
Babies born before 37 weeks of pregnancy are considered premature, and often are at risk of getting sick or suffering…
“What’s your best price on this?” “Mate, it's the price it’s listed at. If I wanted less, I would have…
Continuing to build on the momentum established over the past two years since prioritising the US school market as a…
Australians are a smart bunch. Although the pavlova is disputed, we gladly claim awesome inventions like the black box flight…
Clinical stage pharmaceutical company Pharmaxis (PXS: ASX) is full steam ahead with their Phase 2 clinical trial for flagship drug,…